MedPath

Optimizing place of treatment for young infants presenting with any low mortality risk sign of possible serious bacterial infectio

Not Applicable
Conditions
Health Condition 1: A499- Bacterial infection, unspecified
Registration Number
CTRI/2020/12/029776
Lead Sponsor
Centre for Health Research and Development Society for Applied Studies
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All young infants < 2months days old, living in a geographic area where follow-up for 14 days can be accomplished presenting to outpatient clinics or emergency rooms of participating hospitals will considered for inclusion in this study if they have ONLY one of the following low-risk signs of PSBI:

1. Body temperature >=38°C, or

2. Severe chest indrawing, or

3. Fast breathing ( <7 days old infants).

Exclusion Criteria

1. Weight <2kg at the time of presentation (if age at screening is less than 10 days) or weight for age <-3z, or

2. Signs of critical illness (no movement at all, unable to feed at all, convulsions), or

3.Signs of CSI associated with a high risk of mortality (stopped feeding well, movement only on stimulation, low body temperature < 35.5oC or two or more of the six signs of CSI), or

4. Any sign suggestive of another serious illness/condition, such as major congenital malformations, severe jaundice, conditions requiring major surgery, meningitis, bone or joint infection, severe dehydration, etc., or

5. Appearance of low-mortality risk signs in first 24 hours of life , or

6. Hospitalized for any illness in the previous 2 weeks, or

7. Prior use of injectable antibiotics for the same illness, or

8. Previously included in this study or currently included in any other study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Death <br/ ><br>Presence of any sign of critical illness or sign suggestive of another serious infection <br/ ><br>Presence of any new sign of CSI <br/ ><br>Persistence of presenting sign <br/ ><br>Timepoint: Day 1-15 <br/ ><br>Days 2, 4, 8 <br/ ><br>Days 4, 8, <br/ ><br>Day 8
Secondary Outcome Measures
NameTimeMethod
ot knownTimepoint: Not known
© Copyright 2025. All Rights Reserved by MedPath